About: Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis
Creator	Dos, Andernice Espinosa, Omar Fabiana, Gulin Longhi, Zanetti, Santos Amorim De Matos, Tatiane Antunes, Ednardo Battaglini, Paula
Source	Medline; PMC
abstract	The new coronavirus, COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. Risk factors associated with this disease are age, sex, and the presence of comorbidities, the most common being hypertension, diabetes, and heart disease. The aim of this meta-analysis was to calculate the prevalence and geographical distribution of comorbidities in all patients admitted to intensive care units (ICUs), and the mortality rate of COVID-19. We selected studies based upon epidemiological and clinical descriptions of the patients and mortality from the disease to determine the pooled prevalence of comorbidities in all patients and in mortality cases due to COVID-19. The pooled prevalence was estimated using the random effects model, and odds ratios were used to measure the probability of death for a patient with a comorbidity. The total prevalence of comorbidities in patients with COVID-19 was 42% (95% CI: 25-60), 61% (95% CI: 42-80) in those admitted to the ICU, and 77% (95% CI: 68-86) among death cases; males were the most affected. Hypertension was the most prevalent comorbidity in all three groups studied, accounting for 32%, 26%, and 35%, respectively. The odds ratio of death for a patient with a comorbidity compared to one with no comorbidity was 2.4 (P < 0.0001). The higher the prevalence of comorbidities the higher the odds that the COVID-19 patient will need intensive care or will die, especially if the pre-existing disease is hypertension, heart disease, or diabetes.
has issue date	2020-06-22(xsd:dateTime)
bibo:doi	10.1590/s1678-9946202062043
bibo:pmid	32578683
has license	cc-by-nc
sha1sum (hex)	104736fc41e5cc0f8781c77ea2e1a32b7d84bd33
schema:url	https://doi.org/10.1590/s1678-9946202062043
resource representing a document's title	Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis
has PubMed Central identifier	PMC7310609
has PubMed identifier	32578683
schema:publication	Revista do Instituto de Medicina Tropical de Sao Paulo
resource representing a document's body	covid:104736fc41e5cc0f8781c77ea2e1a32b7d84bd33#body_text
is schema:about of	named entity 'comorbidity' named entity 'Hypertension' named entity 'higher' named entity 'compared' named entity 'heart disease' named entity 'prevalent' named entity 'distribution' named entity 'comorbidity' named entity 'comorbidities' named entity 'prevalence' named entity 'COVID-19' named entity 'disease' named entity 'systematic review' named entity 'Prevalence' named entity 'PREVALENT' named entity 'TO MEASURE' named entity 'intensive care' named entity 'patient' named entity 'prevalence' named entity 'mortality' named entity 'comorbidities' named entity '95% CI' named entity 'diabetes' named entity 'studies' named entity 'March' named entity 'patients' named entity 'cases' named entity 'total' named entity 'meta-analysis' named entity 'ICUs' named entity 'prevalence' named entity 'common' named entity 'comorbidities' named entity 'meta-analysis' named entity '95% CI' named entity 'comorbidities' named entity 'meta-analysis' named entity 'COVID-19' named entity 'heart disease' named entity 'hypertension' named entity 'hypertension' named entity 'coronavirus' named entity 'odds ratios' named entity 'ICU' named entity '95% CI' named entity 'COVID-19' named entity 'intensive care units' named entity 'probability' named entity 'systematic review' named entity 'World Health Organization' named entity '95% CI' named entity 'COVID' named entity 'MERS-CoV' named entity 'Italy' named entity 'comorbidities' named entity 'meta-analysis' named entity 'comorbidity' named entity 'comorbidity' named entity '95% CI' named entity 'United States' named entity 'China' named entity 'COPD' named entity 'systematic review' named entity 'clinical characteristics' named entity 'meta-analysis' named entity '95% CI' named entity 'probability' named entity 'systematic review' named entity 'MeSH' named entity 'epidemiological' named entity 'comorbidities' named entity 'flow chart' named entity 'hypertension' named entity 'clinical characteristics'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software